StonvexLoading…
StonvexStonvexStonvexCore line items from EMBC's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Q4 2025 2025-12-31 | Annual 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $483.00M | $261.20M | $1.08B | $816.40M |
Operating Income | $118.30M | $83.30M | $242.10M | $185.60M |
Net Income | $40.00M | $44.10M | $95.40M | $69.00M |
EPS (Diluted) | $0.67 | $0.74 | $1.62 | $1.18 |
Total Assets | $1.03B | $1.06B | $1.09B | $1.16B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $184.90M | $201.30M | $225.50M | $230.60M |
Free Cash Flow OCF − CapEx | $47.20M | $16.60M | $182.40M | $105.70M |
Shares Outstanding | 59.33M | 59.21M | 58.50M | 58.47M |